Table 2

Contrast enhancement in 74 patients with histologically proven malignant liver tumours or lesions

Liver tumourHypoechoic contrast enhancement
*Hepatocellular carcinomas were variable and less impressive in 13 patients with a heterogeneous enhancing liver parenchyma during the liver specific late phase, also indicating that hepatocellular carcinomas may show some contrast uptake which might lead to misinterpretation. In those 13 patients, repeated contrast examinations were necessary to determine the malignant nature of the lesion due to technical reasons.
Malignant liver lesions (n = 79)79/79
    Metastatic liver tumour (n = 37)37/37
    Hepatocellular carcinoma (n = 33)*33/33
    Cholangiocellular carcinoma (n = 4)4/4
    Lymphoma (n = 4)4/4
    Haemangioendotheliosarcoma (n = 1)1/1